Advertisement
Screener

Stoke Therapeutics, Inc. (STOK) Prepaid Expense and Other Assets, Current

2.3 / 5 stars · 19/41 Roast Me

Stoke Therapeutics, Inc. Prepaid Expense and Other Assets, Current

Stoke Therapeutics, Inc. (STOK) had Prepaid Expense and Other Assets, Current of $12.55 million as of 2022-09-30, per its 10-Q filed 2022-11-14.

Discontinued › Notes

us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2022-11-14

  • 2022-09-30: Prepaid Expense and Other Assets, Current $12.55M.
  • 2022-06-30: Prepaid Expense and Other Assets, Current $13.18M.
  • 2022-03-31: Prepaid Expense and Other Assets, Current $12.29M.
  • 2021-12-31: Prepaid Expense and Other Assets, Current $9.16M.
Period endPrepaid Expense and Other Assets, Current
2022-09-30$12.55M
10-Q · filed 2022-11-14
2022-06-30$13.18M
10-Q · filed 2022-08-08
2022-03-31$12.29M
10-Q · filed 2022-05-10
2021-12-31$9.16M
10-Q · filed 2022-11-14
2021-09-30$8.47M
10-Q · filed 2021-11-08
2021-06-30$8.61M
10-Q · filed 2021-08-10
2021-03-31$7.51M
10-Q · filed 2021-05-10
2020-12-31$6.43M
10-K · filed 2022-03-10
2020-09-30$3.62M
10-Q · filed 2020-11-12
2020-06-30$3.53M
10-Q · filed 2020-08-10
2020-03-31$4.34M
10-Q · filed 2020-05-15
2019-12-31$3.28M
10-K · filed 2021-03-09
2019-09-30$3.25M
10-Q · filed 2019-11-12
2019-06-30$1.50M
10-Q · filed 2019-08-14
2018-12-31$548.00K
10-K · filed 2020-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Innoviva, Inc. (INVA)United States$1.493B4.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Xencor Inc (XNCR)United States$1.776B-7.33
Septerna, Inc. (SEPN)United States$1.783B-63.01